UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
5/17/2013 9:23:36 AM
More...
|
UCB, Inc. (UCBJF.PK) and IBM Corporation (IBM) Collaborate to Personalize Care for Epilepsy Patients
5/16/2013 10:40:35 AM
More...
|
UCB, Inc. (UCBJF.PK) Data Shows Comparable Performance of Clones Cultured in ambr and 100L Bioreactors - Indicating TAP Biosystems' Micro Bioreactor is a Realistic Scale-Down Model for Cell Line Selection
4/10/2013 10:56:33 AM
More...
|
UCB, Inc. (UCBJF.PK) and Emory University Partner to Address Pressing Public Health Issues for People Living With Epilepsy
3/25/2013 10:09:22 AM
More...
|
UCB, Inc. (UCBJF.PK) Release: New Data on Switching Parkinson's Disease Patients With Pre-Existing Gastrointestinal Symptoms From Oral PD Medications to Neupro® (Rotigotine Transdermal System)
3/20/2013 9:02:29 AM
More...
|
UCB, Inc. (UCBJF.PK) Had Positive Trial for Vimpat as Monotherapy
3/5/2013 8:18:38 AM
More...
|
UCB, Inc. (UCBJF.PK) Licenses Global Rights to Tozadenant in Parkinson's Disease From BioTie Therapies Corp. for $20 Million
2/27/2013 7:14:28 AM
More...
|
UCB, Inc. (UCBJF.PK) Announces Regulatory Filings for Cimzia® (Certolizumab Pegol) to Treat Psoriatic Arthritis and Axial Spondyloarthritis
2/20/2013 10:20:43 AM
More...
|
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug
2/12/2013 7:45:04 AM
More...
|
UCB, Inc. (UCBJF.PK) Gets Japan Clearance for Two New Drugs
12/27/2012 7:59:13 AM
More...
|
|